Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
05 Maio 2023 - 12:00PM
Milestone Scientific Inc. (NYSE:MLSS), a leading
developer of computerized drug delivery instruments, that provide
painless and precise injections, today announced that it will host
a conference call at 8:30 AM Eastern Time on Thursday, May 11,
2023, to discuss the company’s financial results for the first
quarter ended March 31, 2023, as well as the company’s corporate
progress and other developments.
The conference call will be available via
telephone by dialing toll free 877-545-0523 for U.S. callers or +1
973-528-0016 for international callers and by entering the access
code: 969476. A webcast and replay of the call may be accessed at
https://www.webcaster4.com/Webcast/Page/2306/48364.
An audio replay of the call will be available
through May 25, 2023, and can be accessed by dialing 877-481-4010
for U.S. callers or +1 919-882-2331 for international callers and
by entering the access code: 48364.
About Milestone Scientific
Inc.
Milestone Scientific Inc. (MLSS), a
technology-focused medical research and development company that
patents, designs and develops innovative injection technologies and
instruments for medical, dental and cosmetic applications.
Milestone Scientific’s computer-controlled systems are designed to
make injections precise, efficient and increase the overall patient
comfort and safety. Their proprietary DPS Dynamic Pressure Sensing
Technology® instruments is the platform to advance the development
of next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or visit
milestonescientific.com.
Contact:Crescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Milestone Scientific (AMEX:MLSS)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025